Cohen & SteersGenworth

Cohen & Steers vs Genworth

Cohen & Steers is a specialized asset manager focused exclusively on real assets like REITs, infrastructure, and commodities, serving institutional and wealth management clients who want inflation-sen...

Investment Analysis

Pros

  • Cohen & Steers specialises in real estate securities and REITs, benefiting from sustained investor demand for listed alternatives and diversification.
  • Recent financial results exceeded analyst expectations, with both earnings and revenue surpassing forecasts, reflecting operational strength and effective management.
  • Analyst consensus acknowledges upward revisions to earnings estimates through 2026, suggesting positive momentum and potential for continued outperformance.

Considerations

  • Assets under management have declined year-over-year and remain significantly below previous peaks, indicating potential challenges in retaining or growing client funds.
  • The stock trades at a substantial premium to Morningstar’s fair value estimate, which may limit near-term upside and increase valuation risk.
  • Heavy reliance on real estate and listed alternatives exposes the firm to sector-specific volatility and potential underperformance during market downturns.

Pros

  • Genworth maintains a leading position in mortgage insurance and long-term care insurance, sectors with high barriers to entry and recurring revenue potential.
  • The company has made progress in deleveraging its balance sheet, improving financial flexibility and reducing interest expense in recent periods.
  • Ongoing efforts to optimise its legacy long-term care business could unlock value if successful, providing a potential catalyst for share price appreciation.

Considerations

  • Genworth’s long-term care insurance portfolio continues to face significant reserve adequacy and claims cost pressures, creating uncertainty around future profitability.
  • Regulatory scrutiny remains elevated for insurers in the long-term care and mortgage sectors, potentially limiting operational flexibility and increasing compliance costs.
  • The company’s growth prospects are constrained by intense competition in core markets, with limited near-term catalysts for material earnings acceleration.

Buy CNS or GNW in Nemo

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Frequently asked questions

CNS
CNS$70.32
vs
GNW
GNW$8.79